COMP <GO>
ORIC vs SVRA // FREE CASH FLOW YIELD
Oric Pharmaceuticals Inc. (NASDAQ) VS. Savara Inc. (NASDAQ) • 15-METRIC TALLY: ORIC 1
— SVRA 4
▲ FREE CASH FLOW YIELD LEADER: SVRA
LAST: $9.07 (-1.84%) • MKT CAP: $957.8M
fcf-yield
-11.99%
LAST: $4.73 (-1.87%) • MKT CAP: $990.3M
fcf-yield
-9.94%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORIC VS. SVRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORIC | SVRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -33.40% | -35.00% | +1.60 | ORIC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -11.99% | -9.94% | -2.05 | SVRA | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | SVRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.3 | 49.2 | -14.90 | SVRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $957.8M | $990.3M | -$32.6M | SVRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORIC REV | SVRA REV | ORIC GROSS % | SVRA GROSS % | ORIC FCF | SVRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $400.4M | $345.9M | — | — | -$111.7M | -$101.1M |
| FY 2024 | $400.1M | $288.9M | — | — | -$113.8M | -$89.1M |
| FY 2023 | $310.2M | $168.0M | — | — | -$85.7M | -$51.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORIC // BETA —
SVRA // BETA —